Influence of Disease Modifying Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Vaccination on Coronavirus Disease 2019 Risk and Outcome in Multiple Sclerosis and Neuromyelitis Optica

Patients suffering from neuro-inflammatory diseases such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) remain vulnerable to COVID-19. We investigated the risk of COVID-19 in MS and NMOSD patients over time, considering the impact of disease-modifying treatments (DMTs...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisler, Jennifer Jessica, Disanto, Giulio, Sacco, Rosaria, Zecca, Chiara, Gobbi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488002/
https://www.ncbi.nlm.nih.gov/pubmed/37685618
http://dx.doi.org/10.3390/jcm12175551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488002/
https://www.ncbi.nlm.nih.gov/pubmed/37685618
http://dx.doi.org/10.3390/jcm12175551

Ejemplares similares